Woolcock Institute of Medical Research 
Sydney, Australia Resumen de la oferta
The Woolcock Institute of Medical Research in Sydney, Australia, invites applications for a PhD focused on developing 3D‑printed lung models. The project aims to create a physiologically relevant artificial respiratory system that combines airway replicas with 3D bioprinting, enabling in‑vitro assessment of pharmacokinetics and pharmacodynamics for inhaled therapeutics. Researchers will also validate the model by comparing new inhalation therapies against industry‑approved testing methods. The role offers a salary and is open to candidates with a strong background in respiratory research, bioprinting, or related fields. Interested applicants should contact Dr Hui Xin Ong at huixin.ong@mq.edu.au for more information.
Generado a partir del contenido almacenado de la oferta. Confirma siempre los detalles en la publicación oficial.
Descripción del proyecto
Inhaled therapies have been a cornerstone in the treatment of patients living with chronic respiratory diseases. While there has been significant progress and research activity within the field of inhalation therapy, only a handful of new inhaled products have successfully progressed to market.
The failure to translate promising inhaled drugs to the clinic will continue to exist due to the absence of a predictive in vitro platform that could accurately mimic the physiological conditions and inhalation processes of the respiratory tract.
We aim to develop an artificial respiratory model that integrates airway replicas with 3D bioprinting as a physiologically relevant platform to assess the pharmacokinetics and pharmacodynamics of novel inhalation therapeutics in vitro. Additionally, the study will also validate the use of the model by testing different inhalation therapies and comparing them to industry-approved testing methodologies.
If you are interested in applying for this PhD opportunity and would like more information, please contact Dr Hui Xin Ong at huixin.ong@mq.edu.au.